It is particularly important to seek medical advice if you are experiencing persistent gastrointestinal side effects from Ozempic that are affecting your ability to maintain a balanced diet, or if you have lost a significant amount of weight rapidly
That would be great. The TIP peptide Lucas developed is a synthetic version of the tip of tumor necrosis factor, or TNF, which, as its name implies, is known to target cancer
However, critical limitations must be acknowledged
It's an investigational drug currently in Phase 3 clinical trials Eli Lilly's TRIUMPH Phase 3 program includes multiple trials for obesity, type 2 diabetes, NASH, and cardiovascular outcomes Expected timeline: FDA submission in 2026, potential approval in 20272028 Phase 2 results showed 24.2% weight loss at 48 weeks, the highest ever recorded for a GLP-1 class medication How to access now: Clinical trial enrollment (free), compounding pharmacies (with important legal caveats), or research peptides (grey market) When approved, retatrutide will be the first triple-agonist obesity medication (GLP-1 + GIP + glucagon) Is Retatrutide FDA Approved
'OKV-119 is designed to mimic many of the physiological effects of fasting without requiring significant changes in feeding routines or disrupting the humananimal bond that often centres around food.' Research conducted by The Royal Veterinary College found that nearly half of all pet cats in the UK are classified as obese
Common examples that insurers look for include type 2 diabetes, high blood pressure (hypertension), high cholesterol (dyslipidemia), and obstructive sleep apnea
